搜尋結果
How digital health companies are capitalizing on the GLP-1 boom
CNBC· 1 日前Novo Nordisk's blockbuster weight loss drug, which contains the second generation GLP-1 ...
Mounjaro And Zepbound Shortages Targeted With $5.3 Billion Eli Lilly Investment
Forbes· 3 日前Eli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting ...
UnitedHealth's unit to launch new drug pricing model next year
Reuters· 6 日前, opens new tab said on Monday its unit OptumRx would offer a new pricing model, starting next year, to help manage insurers ...
Asylum seekers in Hong Kong exploited by drug syndicate, police say
South China Morning Post· 4 日前Ng said the syndicate involved also concealed drugs in tea bags and pet food packages then sold ...
Many Quit Weight-Loss Drugs Too Early for Benefits, Insurer Says
Bloomberg· 5 日前Nearly 60% of Americans who started taking weight-loss drugs between 2014 and 2023 didn’t ...
GSK's experimental drug shows promise in reducing severe asthma attacks
Reuters· 6 日前, opens new tab experimental drug met its primary goal of reducing asthma attacks in a ...
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes Now
Bloomberg· 6 日前... our reporters? China gave the greenlight to Eli Lilly & Co.’s blockbuster drug</ ... ...
Explainer: What does Louisiana's new abortion pill law mean for patients?
Reuters· 1 日前The Louisiana Senate's vote on Thursday to reclassify the two drugs used in medication ...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 3 日前Gyre Pharmaceuticals Co Ltd, also known as Beijing Continent, a Beijing-based innovative drug m ...
Eli Lilly's diabetes drug tirzepatide gets approval in China
Reuters· 6 日前Novo Nordisk's popular diabetes drug Ozempic won approval from China in 2021 and the ...